A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research...

por Steinbild, S, Mross, K, Frost, A, Morant, R, Gillessen, S, Dittrich, C, Strumberg, D, Hochhaus, A, Hanauske, A-R, Edler, L, Burkholder, I, Scheulen, M
Publicado 2007

In vitro irradiation of basement membrane enhances the invasiveness of breast cancer cells

por Paquette, B, Baptiste, C, Therriault, H, Arguin, G, Plouffe, B, Lemay, R
Publicado 2007

Activity of endovesical gemcitabine in BCG-refractory bladder cancer patients: a translational study

por Gunelli, R, Bercovich, E, Nanni, O, Ballardini, M, Frassineti, G L, Giovannini, N, Fiori, M, Pasquini, E, Ulivi, P, Pappagallo, G L, Silvestrini, R, Zoli, W
Publicado 2007

Phase II study of sequential chemotherapy with docetaxel–estramustine followed by mitoxantrone–prednisone in patients with advanced hormone-refractory prostate cancer

por Galli, L, Fontana, A, Galli, C, Landi, L, Fontana, E, Antonuzzo, A, Andreuccetti, M, Aitini, E, Barbieri, R, Di Marsico, R, Falcone, A
Publicado 2007

Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles

por Naito, M, Komohara, Y, Ishihara, Y, Noguchi, M, Yamashita, Y, Shirakusa, T, Yamada, A, Itoh, K, Harada, M
Publicado 2007

Predictors of survival after hepatic resection among patients with colorectal liver metastasis

por Wang, X, Hershman, D L, Abrams, J A, Feingold, D, Grann, V R, Jacobson, J S, Neugut, A I
Publicado 2007

‘1-8 interferon inducible gene family’: putative colon carcinoma-associated antigens

por Tirosh, B, Daniel-Carmi, V, Carmon, L, Paz, A, Lugassy, G, Vadai, E, Machlenkin, A, Bar-Haim, E, Do, M-S, Ahn, I S, Fridkin, M, Tzehoval, E, Eisenbach, L
Publicado 2007

Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer

por Sacca, P, Meiss, R, Casas, G, Mazza, O, Calvo, J C, Navone, N, Vazquez, E
Publicado 2007

Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma

por Pritchard-Jones, R O, Dunn, D B A, Qiu, Y, Varey, A H R, Orlando, A, Rigby, H, Harper, S J, Bates, D O
Publicado 2007

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification

por Schleiermacher, G, Michon, J, Huon, I, d'Enghien, C Dubois, Klijanienko, J, Brisse, H, Ribeiro, A, Mosseri, V, Rubie, H, Munzer, C, Thomas, C, Valteau-Couanet, D, Auvrignon, A, Plantaz, D, Delattre, O, Couturier, J
Publicado 2007

Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chron...

por Pepper, C, Lowe, H, Fegan, C, Thurieau, C, Thurston, D E, Hartley, J A, Delavault, P
Publicado 2007

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer:...

por Okamoto, H, Watanabe, K, Kunikane, H, Yokoyama, A, Kudoh, S, Asakawa, T, Shibata, T, Kunitoh, H, Tamura, T, Saijo, N
Publicado 2007

Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells

por Moniaux, N, Chaturvedi, P, Varshney, G C, Meza, J L, Rodriguez-Sierra, J F, Aubert, J-P, Batra, S K
Publicado 2007

Tissue level, activation and cellular localisation of TGF-β1 and association with survival in gastric cancer patients

por Hawinkels, L J A C, Verspaget, H W, van Duijn, W, van der Zon, J M, Zuidwijk, K, Kubben, F J G M, Verheijen, J H, Hommes, D W, Lamers, C B H W, Sier, C F M
Publicado 2007

The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain T...

por Mauer, M, Stupp, R, Taphoorn, M J B, Coens, C, Osoba, D, Marosi, C, Wong, R, de Witte, O, Cairncross, J G, Efficace, F, Mirimanoff, R O, Forsyth, P, van den Bent, M J, Weller, M, Bottomley, A
Publicado 2007

Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity

por Helbekkmo, N, Sundstrøm, S H, Aasebø, U, Fr Brunsvig, P, von Plessen, C, Hjelde, H H, Garpestad, O K, Bailey, A, Bremnes, R M
Publicado 2007

Clinical pharmacodynamic factors in docetaxel toxicity

por Puisset, F, Alexandre, J, Treluyer, J-M, Raoul, V, Roché, H, Goldwasser, F, Chatelut, E
Publicado 2007

Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer

por Delord, J-P, Bennouna, J, Artru, P, Perrier, H, Husseini, F, Desseigne, F, François, E, Faroux, R, Smith, D, Piedbois, P, Naman, H, Douillard, J Y, Bugat, R
Publicado 2007

Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer

por Tam, L, McGlynn, L M, Traynor, P, Mukherjee, R, Bartlett, J M S, Edwards, J
Publicado 2007

Medical student teaching in the UK: how well are newly qualified doctors prepared for their role caring for patients with cancer in hospital?

por Cave, J, Woolf, K, Dacre, J, Potts, H W W, Jones, A
Publicado 2007